Transseptal antegrade transcatheter aortic valve replacement for patients with no other access approach - A contemporary experience

Catheterization and Cardiovascular Interventions

Volumn 82, Issue 6, 2013, Pages 987-993

  Cohen, Mauricio G ^a   Singh, Vikas ^a   Martinez, Claudia A ^a   O'Neill, Brian P ^a   Alfonso, Carlos E ^a   Martinezclark, Pedro O ^a   Heldman, Alan W ^a   O'Neill, William W ^a  

^a UNIVERSITY OF MIAMI HOSPITAL   (United States)

Author keywords

aortic stenosis; transcatheter aortic valve replacement; transseptal approach

Indexed keywords

NITINOL;

ACUTE KIDNEY FAILURE; AGED; AORTA STENOSIS; AORTIC VALVE REPAIR; ARTERY DIAMETER; ARTICLE; ARTIFICIAL HEART PACEMAKER; BALLOON CATHETER; CARDIAC RESYNCHRONIZATION THERAPY; CASE STUDY; CATHETER SHEATH; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPUTED TOMOGRAPHY SCANNER; DISEASE SEVERITY; FEASIBILITY STUDY; FEMALE; FLUOROSCOPY; FOLLOW UP; FRAIL ELDERLY; GERIATRIC REHABILITATION; GUIDING CATHETER; HEART HEMODYNAMICS; HEART VALVE PROSTHESIS; HEART VENTRICLE THROMBOSIS; HUMAN; LUNG DISEASE; MALE; OBSERVATIONAL STUDY; PERCUTANEOUS AORTIC VALVE; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; STERNOTOMY; SURGICAL APPROACH; SURGICAL MORTALITY; SURGICAL SNARE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSSEPTAL ANTEGRADE TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; VASCULAR ACCESS; VASCULAR GUIDE WIRE; VASCULAR SNARE; VERTEBRAL CANAL STENOSIS; WIRE LOOP; ADVERSE EFFECTS; AORTIC VALVE STENOSIS; DEVICES; FLORIDA; HEART CATHETERIZATION; HEART VALVE REPLACEMENT; HEMODYNAMICS; MORTALITY; PATHOPHYSIOLOGY; PATIENT SELECTION; PROCEDURES; PROSTHESIS DESIGN; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; FEASIBILITY STUDIES; FEMALE; FLORIDA; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; MALE; PATIENT SELECTION; PROSTHESIS DESIGN; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84887321021     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25036     Document Type: Article

References (9)

1. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S,. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363: 1597-1607.
2. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ,. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364: 2187-2198.
3. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB,. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: First human case description. Circulation 2002; 106: 3006-3008.
4. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW,. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008; 4: 242-249.
5. Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R, Sinhal A, Carere RG, Munt B, Ricci D, Ye J, Cheung A, Lichtenstein SV,. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007; 116: 755-763.
6. Jilaihawi H, Bonan R, Asgar A, Ibrahim R, Spyt T, Chin D, Kovac J,. Anatomic suitability for present and next generation transcatheter aortic valve prostheses: Evidence for a complementary multidevice approach to treatment. JACC Cardiovasc Interv 3: 859-866.
7. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW,. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: A consensus report from the valve academic research consortium. J Am Coll Cardiol 57: 253-269.
8. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Sebagh L, Bash A, Nusimovici D, Litzler PY, Bessou JP, Leon MB,. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 2004; 43: 698-703.
9. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D, Tapiero S, Litzler PY, Bessou JP, Babaliaros V,. Treatment of calcific aortic stenosis with the percutaneous heart valve: Mid-term follow-up from the initial feasibility studies: The French experience. J Am Coll Cardiol 2006; 47: 1214-1223.